Guangdong Zhongsheng Pharmaceutical Hits Day High with 3.25% Surge

Guangdong Zhongsheng Pharmaceutical Co., Ltd. has shown significant activity today, gaining 3.25% and reaching an intraday high of CNY 23.96. This performance stands in contrast to the China Shanghai Composite, which declined by 0.73% on the same day. Over the past month, the stock has surged by 27.8%, while its year-to-date performance reflects a robust increase of 24.03%. Despite the recent gains, the company has faced challenges in long-term growth, with net sales increasing at an annual rate of only 4.95% over the last five years. However, the company reported a remarkable net profit growth of 296.49% in its latest quarterly results, marking four consecutive quarters of positive outcomes. The operating cash flow reached its highest at CNY 497.18 million, and the return on capital employed (ROCE) also peaked at 7.19%. With a market capitalization of CNY 15,511 million, Guangdong Zhongsheng operates within the pharmaceuticals and biotechnology sector. The stock's performance over the past year has outpaced the broader market, generating a return of 72.96% compared to the China Shanghai Composite's 20.96%.